Anumana to Showcase AI-Driven Cardiovascular Solutions at AHA and NAPCRG 2024
Company to highlight how its ECG-AI® algorithms enable earlier cardiovascular disease detection
November 14, 2024
Anumana Receives First and Only FDA Clearance for ECG-AI Cardiac Amyloidosis Algorithm Using a Standard 12-Lead ECG